Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP189309.RAKg-ljO2aKHRRnMyp6-btnVYFH9yYNbdBVRYDeJpwFGs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP189309.RAKg-ljO2aKHRRnMyp6-btnVYFH9yYNbdBVRYDeJpwFGs130_assertion type Assertion NP189309.RAKg-ljO2aKHRRnMyp6-btnVYFH9yYNbdBVRYDeJpwFGs130_head.
- NP189309.RAKg-ljO2aKHRRnMyp6-btnVYFH9yYNbdBVRYDeJpwFGs130_assertion description "[Within high-grade MEC, MECT1/MAML2 positive tumors had lower rates of anaplasia (P=0.001), and mitotic counts (P=0.012).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP189309.RAKg-ljO2aKHRRnMyp6-btnVYFH9yYNbdBVRYDeJpwFGs130_provenance.
- NP189309.RAKg-ljO2aKHRRnMyp6-btnVYFH9yYNbdBVRYDeJpwFGs130_assertion evidence source_evidence_literature NP189309.RAKg-ljO2aKHRRnMyp6-btnVYFH9yYNbdBVRYDeJpwFGs130_provenance.
- NP189309.RAKg-ljO2aKHRRnMyp6-btnVYFH9yYNbdBVRYDeJpwFGs130_assertion SIO_000772 20588178 NP189309.RAKg-ljO2aKHRRnMyp6-btnVYFH9yYNbdBVRYDeJpwFGs130_provenance.
- NP189309.RAKg-ljO2aKHRRnMyp6-btnVYFH9yYNbdBVRYDeJpwFGs130_assertion wasDerivedFrom befree-20140225 NP189309.RAKg-ljO2aKHRRnMyp6-btnVYFH9yYNbdBVRYDeJpwFGs130_provenance.
- NP189309.RAKg-ljO2aKHRRnMyp6-btnVYFH9yYNbdBVRYDeJpwFGs130_assertion wasGeneratedBy ECO_0000203 NP189309.RAKg-ljO2aKHRRnMyp6-btnVYFH9yYNbdBVRYDeJpwFGs130_provenance.